Advertisement

The Two Pandemics

  • Michelle M. Kittleson
    Correspondence
    Requests for reprints should be addressed to Michelle M. Kittleson, MD PhD, Cedars-Sinai Smidt Heart Institute, 8670 Wilshire Boulevard, 2nd floor, Los Angeles, CA 90211.
    Affiliations
    Department of Cardiology, Cedars-Sinai Smidt Heart Institute, Los Angeles, Calif
    Search for articles by this author
      In the Heart Transplant Clinic, her first words were always, “How are the kids?” In the 10 years since her transplant, she had delighted in my 3 pregnancies and admired the babies I toted around at transplant holiday parties. But at this visit, her first words were, “You're from India, right?”
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Genuardi MV
        • Moss N
        • Najjar SS
        • et al.
        Coronavirus disease 2019 in heart transplant recipients: risk factors, immunosuppression, and outcomes.
        J Heart Lung Transplant. 2021; 40: 926-935
        • Qin CX
        • Moore LW
        • Anjan S
        • et al.
        Risk of breakthrough SARS-CoV-2 infections in adult transplant recipients.
        Transplantation. 2021; 105: e265-e266
        • Ravanan R
        • Mumford L
        • Ushiro-Lumb I
        • et al.
        Two doses of SARS-CoV-2 vaccines reduce risk of death due to COVID-19 in solid organ transplant recipients: preliminary outcomes from a UK registry linkage analysis.
        Transplantation. 2021; 105: e263-e264
      1. Jones J. Epidemiology of COVID-19 in children aged 5-11 years. 2021. Available at: https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-11-2-3/03-COVID-Jefferson-508.pdf. Accessed February 3, 2022.

        • Montgomery J
        • Ryan M
        • Engler R
        • et al.
        Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military.
        JAMA Cardiol. 2021; 6: 1202-1206
        • Høeg TB
        • Krug A
        • Stevenson J
        • Mandrola J
        SARS-CoV-2 mRNA vaccination-associated myocarditis in children ages 12-17: a stratified national database analysis.
        medRxiv. 2021; (Available at:) (Accessed May 8, 2022)
        • Barda N
        • Dagan N
        • Ben-Shlomo Y
        • et al.
        Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting.
        N Engl J Med. 2021; 385: 1078-1090
        • Hause AM
        • Baggs J
        • Marquez P
        • et al.
        COVID-19 vaccine safety in children aged 5-11 years – United States, November 3-December 19, 2021.
        MMWR Morb Mortal Wkly Rep. 2021; 70: 1755-1760
        • Olson SM
        • Newhams MM
        • Halasa NB
        • et al.
        Effectiveness of Pfizer-BioNTech mRNA vaccination against COVID-19 hospitalization among persons aged 12-18 years – United States, June-September 2021.
        MMWR Morb Mortal Wkly Rep. 2021; 70: 1483-1488
        • Zambrano LD
        • Newhams MM
        • Olson SM
        • et al.
        Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12-18 years – United States, July-December 2021.
        MMWR Morb Mortal Wkly Rep. 2022; 71: 52-58
        • Levy M
        • Recher M
        • Hubert H
        • et al.
        Multisystem inflammatory syndrome in children by COVID-19 vaccination status of adolescents in France.
        JAMA. 2022; 327: 281-283
        • Ouldali N
        • Bagheri H
        • Salvo F
        • et al.
        Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study.
        Lancet Reg Health Eur. 2022; 29: 100393https://doi.org/10.1016/j.lanepe.2022. 100393